Stock NEOSTEM INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. NeoStem Inc Nasdaq

Equities

US6406504042

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for NeoStem Inc
05-09 Transcript : Lisata Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024
05-09 Lisata Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Adjusts Lisata Therapeutics' Price Target to $15 From $6, Keeps Buy Rating
MT
HC Wainwright Adjusts Price Target on Caladrius Biosciences to $6 From $8, Reiterates Buy Rating
MT
CALADRIUS BIOSCIENCES : Chardan Suspends Coverage on Caladrius Biosciences at Buy Rating With $6 Price Target
MT
CALADRIUS BIOSCIENCES : Brookline Capital Management Adjusts Caladrius Biosciences PT to $10 From $7, Maintains Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LSTA Stock
  4. Stock
  5. News NeoStem Inc
  6. Analyst Reco.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW